J. Lee
7 Papers
1 Citations
J. Lee is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 7 publications.
Chat about Author
Papers
Translating metagenomics into clinical practice of complex paediatric neurological presentations
Justin Penner,Jack Hassell,J. R. Brown,Kshitij Mankad,Nathaniel Storey,L. Atkinson,Nishanthy Ranganathan,Alexander Lennon,J. Lee,Aleksandra Kopeć,Dina Shah,C. T. Venturini,Giles Dixon,Susnata De,James Hatcher,Kathy Harris,Kristian Aquilina,Maaike A A Kusters,Karyn Moshal,Delane Shingadia,Austen Worth,Giuseppe Lucchini,A. Merve,T. Jacques,Alison Bamford,Marios Kaliakatsos,J. P. Breuer,Sofia Morfopoulou +27 more
TL;DR: In this article , clinical metagenomics (CMg) is used by neuro-infection multidisciplinary teams (MDTs) to detect the causative pathogen in 14/60 (23%), with 12/36 patients known to be immunocompromised.
A single-centre, observational study to evaluate immune response to Covid-19 vaccines in immunocompromised patients with haematological disorders (COVAC-IC)
D. Chandra,COAVC-IC INVESTIGATORS,Leigh A. O’Mara,Lynda Bailey,Melanie Aspey,Md. Asaduzzaman,K. Banavathi,Spencer T. Lea,Rosemarie M. Bowler,J. P. C. Prasangika,N Phillips,Fauzia Wasim,B. Badugama,N. Kamran,K. L. R. L. Perera,F. Bano,S Pillai,Philip C. Dyer,Mohammad Amimul Ihsan Aquil,Susan Goddard,Atieme J. Ogbolosingha,Alda Remegoso,J. Lee,Kaitlyn M. Watts,K. Karunanithi +24 more
TL;DR: In this article , the authors evaluated immunological response to Covid-19 vaccines in immunocompromised haematology patients and compared with healthy controls and found no significant difference in T cell and total anti SARS CoV 2 spike antibody and T cell response between study and control group patients.
1
Grey matter morphometric biomarkers for classifying early schizophrenia and PD psychosis: a multicentre study
Franziska Knolle,Shyam Sundar Arumugham,Roger A. Barker,M. Chee,Azucena Justicia,Nitish Kamble,J. Lee,Abhishek Lenka,Stephanie J. Lewis,G. Murray,P. K. Patel,Jit Saini,Jennifer Y. Y. Szeto,Reenu Yadav,J. Zhou,Kadri Koch +15 more
TL;DR: Results provide first evidence that GM volume within specific SCNs may serve as a biomarker for identifying FEP and PDP, indicating some commonality of underlying mechanisms in both early schizophrenia and PD psychosis.
1
Patterns of early neocortical amyloid beta accumulation: a positron emission tomography population-based study
Emily Lecy,H.K. Min,Christopher Apgar,Daniel Maltais,Emily S. Lundt,Sabrina M. Albertson,Matthew L. Senjem,Christopher G. Schwarz,Hugo Botha,Jon Graff-Radford,D. Jones,Prashanthi Vemuri,Kejal Kantarci,David S. Knopman,Ronald C. Petersen,C. R. Jack,J. Lee,A. J. Lowe +17 more
TL;DR: In this article , the authors investigated amyloid-beta signals in the per-reshold SUVr range using Pittsburgh compound B (PiB) PET in a population-based study cross-sectionally and longitudinally.
Use of an extended KDIGO definition to diagnose acute kidney injury in patients with COVID-19: A multinational study of the ISARIC cohort
Marina Wainstein,S. MacDonald,D. Fryer,K. B. Young,Steve Webb,H Begum,Alistair Nichol,J. Lee,Vijayan Balan,J. Perren Cobb,Alice Burrell,Kalynn Kennon,S. Strudwick,Sophie H. Kelly,Malcolm G Semple,Laurent Merson,B. Citarella,Susmita Murthy,Patrick Rossignol,Rolando Claure-Del Granado,Sophie Shrapnel +20 more
TL;DR: The use of an extended KDIGO definition to diagnose AKI in this population resulted in a significantly higher incidence rate compared to traditional KDigO criteria and additional cases of AKI appear to be occurring in the community or early in the hospital admission and are associated with worse outcomes than those without AKI.